As of 2025-07-15, the Relative Valuation of Celldex Therapeutics Inc (CLDX) is (57.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.36 USD, the upside of Celldex Therapeutics Inc based on Relative Valuation is -345.6%.
The range of the Relative Valuation is (38.25) - (72.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 26.9x | 20.3x |
| Forward P/E multiples | 14.2x - 30.4x | 22.3x |
| Fair Price | (38.25) - (72.47) | (57.38) |
| Upside | -263.8% - -410.2% | -345.6% |
| Date | P/E |
| 2025-07-14 | -8.67 |
| 2025-07-11 | -8.50 |
| 2025-07-10 | -8.42 |
| 2025-07-09 | -8.34 |
| 2025-07-08 | -7.92 |
| 2025-07-07 | -7.79 |
| 2025-07-03 | -8.17 |
| 2025-07-02 | -8.21 |
| 2025-07-01 | -7.87 |
| 2025-06-30 | -7.55 |
| 2025-06-27 | -7.53 |
| 2025-06-26 | -7.86 |
| 2025-06-25 | -7.97 |
| 2025-06-24 | -8.04 |
| 2025-06-23 | -7.57 |
| 2025-06-20 | -7.61 |
| 2025-06-18 | -7.73 |
| 2025-06-17 | -7.45 |
| 2025-06-16 | -7.55 |
| 2025-06-13 | -7.89 |
| 2025-06-12 | -7.55 |
| 2025-06-11 | -7.58 |
| 2025-06-10 | -7.77 |
| 2025-06-09 | -7.69 |
| 2025-06-06 | -7.93 |
| 2025-06-05 | -7.25 |
| 2025-06-04 | -7.30 |
| 2025-06-03 | -7.38 |
| 2025-06-02 | -7.41 |
| 2025-05-30 | -7.34 |
| 2025-05-29 | -7.36 |
| 2025-05-28 | -6.93 |
| 2025-05-27 | -7.34 |
| 2025-05-23 | -7.55 |
| 2025-05-22 | -7.56 |
| 2025-05-21 | -7.41 |
| 2025-05-20 | -7.61 |
| 2025-05-19 | -7.76 |
| 2025-05-16 | -7.59 |
| 2025-05-15 | -7.46 |
| 2025-05-14 | -7.03 |
| 2025-05-13 | -7.28 |
| 2025-05-12 | -7.49 |
| 2025-05-09 | -6.80 |
| 2025-05-08 | -7.25 |
| 2025-05-07 | -7.02 |
| 2025-05-06 | -6.83 |
| 2025-05-05 | -7.53 |
| 2025-05-02 | -7.67 |
| 2025-05-01 | -7.69 |